Skip to main navigation Skip to search Skip to main content

Seronegative Lyme Disease

  • David A. Relman
  • , Gideon Nesher
  • , Thomas G. Osborn
  • , Terry L. Moore
  • , Felix Mor
  • , Leonard Leibovici
  • , Raymond J. Dattwyler
  • , David J. Volkman
  • , Benjamin J. Luft
  • , John J. Halperin
  • , Josephine Thomas
  • , Marc G. Golightly
  • Stanford University
  • Saint Louis University
  • Rabin Medical Center Israel
  • Stony Brook University

Research output: Contribution to journalLetterpeer-review

4 Scopus citations

Abstract

To the Editor: Dattwyler and his associates (Dec. 1 issue)1 make important and provocative observations about a group of patients with a clinical diagnosis of chronic Lyme disease who have no apparent serologic response to the causative agent, Borrelia burgdorferi. The specific T-cell proliferative response in these patients was similar to that found in a group of seropositive patients with chronic Lyme disease, suggesting that in some persons with this clinical syndrome, the T-cell and B-cell responses to B. burgdorferi are vastly unequal. One point needs clarification: although the serologic status of the patients seems to have been known…

Original languageEnglish
Pages (from-to)1279-1280
Number of pages2
JournalNew England Journal of Medicine
Volume320
Issue number19
DOIs
StatePublished - May 11 1989

Fingerprint

Dive into the research topics of 'Seronegative Lyme Disease'. Together they form a unique fingerprint.

Cite this